The alteration of parameters was expressed as compared with healthy control group. DC diabetic control, RES resveratrol treatment 10 mg/kg, SLN-RES resveratrol-loaded solid lipid nanoparticles containing 10 mg/kg of resveratrol, FBS fasting blood sugar, HOMA homeostasis model assessment-estimated insulin resistance. Data were expressed as mean ± SD
αCompared to the DC group
δThere was a significant difference between RES and SLN-RES group (p < 0.05)
πRestored to the HC group (there was no significant difference compared to the HC group (p > 0.05)).